EGFR and cancer: The cytotoxic effects of DSF-102 against human triple negative breast MDA-MB-231 and human colon HCT-15 cancer cells, overexpressing EGFR, as well as on human melanoma cells, poorly expressing EGFR, were also determined, to obtain preliminary data on the specificity of action of the compound (Table 1).